Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells

Authors
Citation
Lf. Qin et Iol. Ng, Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells, CANCER LETT, 172(1), 2001, pp. 7-15
Citations number
25
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
172
Issue
1
Year of publication
2001
Pages
7 - 15
Database
ISI
SICI code
0304-3835(20011022)172:1<7:EEOPEC>2.0.ZU;2-J
Abstract
The effects of exogenous expression of p21(WAFI/CIPI) in hepatoma cells wer e examined. Two stably p21(WAFI/CIPI)-transfected clones and one clone tran sfected with expression vector only were used for study. Introduction of p2 1(WAFI/CIPI) resulted in significant cell growth inhibition, and the magnit ude of the cell growth inhibition in these transfected cells was proportion al to the level of p21(WAFI/CIPI) protein expressed. Exogenous p21(WAFI/CIP I) expression also significantly enhanced chemosensitivity to cisplatin. In addition, apoptosis occurred earlier in cells transfected with p21(WAFI/CI PI) after cisplatin treatment. These findings raise the potential that forc ed upregulation of p21(WAFI/CIPI) in hepatocellular carcinoma (HCC) may red uce the doses of cisplatin to achieve similar responses and suggest the pos sible use of p21(WAFI/CIPI) in HCC treatment. (C) 2001 Elsevier Science Ire land Ltd. All rights reserved.